New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
11:46 EDTINO, SKX, DECK, QLIK, TTS, INFN, MLNX, ANGI, PBYI, CRUSOptions with decreasing implied volatility
Options with decreasing implied volatility: INO PBYI ANGI MLNX INFN TTS QLIK DECK SKX CRUS
News For INO;PBYI;ANGI;MLNX;INFN;TTS;QLIK;DECK;SKX;CRUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 24, 2014
10:15 EDTSKXSkechers weakness a buying opportunity, says Sterne Agee
Subscribe for More Information
10:11 EDTSKXSkechers lower after Buckingham comments on sales data
Subscribe for More Information
10:09 EDTSKXSkechers weakness a buying opportunity, says Sterne Agee
06:02 EDTINOInovio Ebola vaccine moving into human trial with GeneOne Life Science
Subscribe for More Information
September 22, 2014
08:10 EDTINOInovio initiates phase I clinical trial in patients with aerodigestive cancers
Inovio announced it has initiated a phase I clinical trial in patients with aerodigestive cancers. The trial will evaluate the safety, tolerability, and immunogenicity of INO-3106. This immunotherapy targets human papillomavirus type 6, which causes most aerodigestive cancers. This study is part of Inovio's strategy to broadly expand clinical development of its DNA-based immune therapy products to treat different HPV types and the many diseases they cause. It is a phase I, open label compassionate study enrolling patients with invasive cancer who have exhausted all other treatment options. The study will test Inovio's immunotherapy, INO-3106, alone or in combination with DNA-based IL-12, Inovio's proprietary immune activator, in subjects with HPV-6 associated aerodigestive malignancies. Successful results could open a path to pursuing an FDA orphan designation for aerodigestive cancers.
September 19, 2014
10:53 EDTINO Options with increasing implied volatility: ESI INO VALE AGNC
Subscribe for More Information
08:16 EDTINFNInfinera price target raised to $15 from $12 at MKM Partners
Subscribe for More Information
08:11 EDTCRUSTriQuint chip among those in iPhone 6 Plus, iFixit reports
Subscribe for More Information
08:03 EDTCRUSInvenSense, NXP, RF Micro chips included in iPhone 6, iFixit reports
Subscribe for More Information
07:10 EDTDECKDeckers Outdoor seeing strong growth across brands, says Piper Jaffray
Subscribe for More Information
September 18, 2014
15:52 EDTANGIAngie's List upside potential outweighs downside risk, says Barrington
After meetings with management, Barrington said Angie's List is taking the right steps in improving its website and mobile apps. The firm believes there is "much more" upside potential than downside risk in the stock and maintains its Outperform rating and $15 price target on the shares.
09:22 EDTSKXBack to school season healthy for footwear, says Sterne Agee
Subscribe for More Information
07:32 EDTANGIMKM Partners to hold a conference
Subscribe for More Information
September 17, 2014
12:46 EDTSKXSkechers pullback a buying opportunity, says Wunderlich
Subscribe for More Information
12:43 EDTSKXSkechers reiterated Buy at Wunderlich
Subscribe for More Information
11:16 EDTSKXOptions with increasing implied volatility:
Options with increasing implied volatility: WB SDRL TAP AGNC IYR SKX
10:00 EDTMLNXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:01 EDTSKXSkechers files infringement lawsuit against DB Shoe Company
Subscribe for More Information
07:02 EDTQLIKQlik Technologies licensing growth poised to accelerate, says Pacific Crest
Subscribe for More Information
September 16, 2014
16:27 EDTMLNXMellanox initiated with a Neutral at Sterne Agee
Target $46.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use